FDA Center for Drug Evaluation & Research Issues Warning Letter to JW Nutritional
May 20, 2026
May 20, 2026
WASHINGTON, May 20 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to JW Nutritional LLC from its Center for Drug Evaluation and Research:
* * *
Recipient: Mr. Jesse Windrix, President, JW Nutritional LLC, 4700 S. Hardin Blvd., Suite 260, McKinney, TX 75070-2411, United States, jesse@jwnutritional.com
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
* * *
Recipient: Mr. Jesse Windrix, President, JW Nutritional LLC, 4700 S. Hardin Blvd., Suite 260, McKinney, TX 75070-2411, United States, jesse@jwnutritional.com
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
